Veterinary Rapid Tests - Global Strategic Business Report

The global market for Veterinary Rapid Tests was estimated at US$820.2 Million in 2024 and is projected to reach US$1.3 Billion by 2030, growing at a CAGR of 7.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Veterinary Rapid Tests market.

Global Veterinary Rapid Tests Market - Key Trends & Drivers Summarized

Why Are Rapid Diagnostic Tests Vital in Veterinary Disease Management?

Veterinary rapid tests are point-of-care diagnostic tools designed to deliver quick results for infectious diseases, metabolic conditions, and physiological markers in animals. These tests are used across clinical, on-farm, and field settings, allowing veterinarians and animal handlers to make immediate decisions regarding treatment, isolation, or further diagnostic steps. Rapid tests are available for companion animals, livestock, poultry, and exotic species, and commonly target pathogens such as parvovirus, Giardia, FeLV/FIV, bovine viral diarrhea virus, and avian influenza.

The format typically includes lateral flow assays, immunochromatographic strips, or ELISA-based devices packaged for single-use convenience. These tests require minimal equipment and training, making them suitable for emergency care, mobile veterinary units, and rural areas. As animal health becomes closely tied to zoonotic surveillance and agricultural biosecurity, rapid testing supports early disease identification and reduces the risk of large-scale outbreaks or unnecessary antibiotic use.

How Are Product Development and Clinical Validation Evolving?

Veterinary rapid test manufacturers are increasingly focusing on sensitivity, specificity, and cross-species applicability. Test formats are being adapted for different sample matrices such as blood, feces, saliva, or milk to accommodate varied clinical settings and species. Multiplexing technology is gaining traction, allowing simultaneous detection of multiple pathogens from a single sample, which is especially valuable in livestock herd health management and small animal clinics.

Manufacturers are also emphasizing shelf stability and packaging durability to improve product reliability in varying field conditions. Clinical validation is being strengthened through alignment with OIE guidelines and independent laboratory evaluations. In some markets, rapid tests are also becoming integrated into broader veterinary diagnostic workflows through compatibility with reader devices that digitize results, store data, and generate health records, thereby improving documentation and continuity of care.

What Market Segments Are Driving Adoption of On-Site Veterinary Diagnostics?

Rapid tests are widely adopted in small animal clinics where immediate diagnosis supports quick decision-making for contagious or acute illnesses. In livestock settings, they are used to detect economically significant diseases that affect herd productivity or require movement restrictions. For instance, tests for mastitis, brucellosis, and foot-and-mouth disease enable rapid screening in field conditions. Wildlife and zoo health monitoring programs also benefit from non-laboratory diagnostics that reduce the need for sedation and sample transport.

In equine medicine, rapid diagnostics are used for detecting respiratory infections and reproductive conditions, especially during breeding and competition seasons. Additionally, poultry and aquaculture sectors are deploying lateral flow tests for disease surveillance under high-density farming conditions. These sectors require fast, cost-effective methods to screen large populations with minimal disruption. Demand for easy-to-use diagnostics is also growing among animal shelters, NGOs, and mobile veterinary services, which often operate under resource constraints.

What Factors Are Accelerating Market Expansion Across Species and Geographies?

Growth in the veterinary rapid tests market is driven by several factors related to companion animal care, livestock disease control, and advancements in field diagnostics. Rising pet ownership and veterinary clinic density are increasing demand for fast and affordable diagnostics in urban and suburban areas. In parallel, disease outbreaks in poultry, swine, and cattle populations are prompting greater investment in on-site testing tools to reduce economic losses and limit spread. Increased adoption of preventive animal health practices, especially in emerging markets, is supporting broader test deployment. Manufacturers are offering disease-specific panels customized for regional prevalence patterns, enhancing relevance and uptake. Technological advancements in assay design, sample handling, and data integration are improving accuracy and facilitating integration with digital veterinary records. Ongoing efforts by animal health authorities to improve early disease detection and surveillance infrastructure are further reinforcing the role of rapid tests in veterinary diagnostics worldwide.

Scope Of Study:

The report analyzes the Veterinary Rapid Tests market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Product (Veterinary Rapid Test Kits, Veterinary Rapid Test Readers); Animal Type (Livestock Animals, Companion Animals); Application (Bacterial Diseases Application, Viral Diseases Application, Parasitic Diseases Application, Allergies Application, Other Applications)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Veterinary Rapid Test Kits segment, which is expected to reach US$935.5 Million by 2030 with a CAGR of a 8.9%. The Veterinary Rapid Test Readers segment is also set to grow at 5.1% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $223.5 Million in 2024, and China, forecasted to grow at an impressive 12.4% CAGR to reach $277.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Veterinary Rapid Tests Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Veterinary Rapid Tests Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Veterinary Rapid Tests Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abaxis (part of Zoetis), AgriBio, Antech Diagnostics (Mars Inc.), BioMérieux SA, BioNote, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 36 companies featured in this Veterinary Rapid Tests market report include:

• Abaxis (part of Zoetis)
• AgriBio
• Antech Diagnostics (Mars Inc.)
• BioMérieux SA
• BioNote, Inc.
• Biopanda Reagents Ltd
• Boehringer Ingelheim
• CorisBioConcept SPRL
• Dutch Diagnostics
• Fassisi GmbH
• Heska Corporation (Mars Inc.)
• IDEXX Laboratories, Inc.
• MEGACOR Diagnostik GmbH
• Neogen Corporation
• Prometheus Bio Inc.
• Randox Laboratories
• Siemens Healthcare GmbH
• Swissavans AG
• Thermo Fisher Scientific, Inc.
• Virbac
• Woodley Equipment Company Ltd

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.